Wegner.Chirurgishe Bemerkunjen uber die peritonealhohle. mit besonderer beruchsichtigung der ovariotomie.Arch fur Klin Chir1876; 20: 51–145.
2.
RosenakS., SimonP.Experimentalle untersuchunger uber die peritoneale ausscheidung harnfflichtiger substanzan aus den blute, Mitt. Orenzgelieten.Med U Chir1926; 39: 391–408.
PutmanI.The living peritoneum as a dialysing membrane.Am I Physiol1923; 63: 548–565.
5.
OdelH.M., FerrisD.O., PowerH.Peritoneal lavage as an effective means of external excretion.Am I Med1950; 9: 63–77.
6.
AnnstrongV.W., FuchsC., SchelerF.Effect of dialysate glucose overload on plasma glucose and insulin levels in CAPD patients. In: OahlO.M., KesselM., NolphK.D.. eds. Advances in peritoneal dialysis.Excerpta Medica, 1981: 421–423.
7.
VasS.I., SuweA., WeatherheadI.Natural defence mechanisms of the peritoneum: The effect of peritoneal dialysis fluid on polymorphonuclear cells. In: AtkinsR.C., ThomsonN.M., FarrellP.C.. eds. Peritoneal dialysis.Churchill Livingstone, 1981: 41–51.
8.
OreopoulosD.O., CrasswellerP., KatirtzoglouAAmino acid as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis. In: LegrainM. ed. Continuous ambulatory peritoneal dialysis.Excerpta Medica1979: 335–340.
9.
PyleK.W., MoncreifI.W., PopovichR.P.Peritoneal transport evaluation in CAPD. In: MoncreifI.W., PopovichR.P.. eds. CAPD update.Masson Publishing, 1981: 35–52.
10.
RajaK.M., KramerM.S., RosenbaumILContrasting changes in solute transport and ultrafiltration with peritonitis in CAPD patients.Trans Am Soc Artiflntern Organs1981; 27: 6870.
NolphK.D., SorkinM., RubinIContinuous ambulatory peritoneal dialysis: Three years experience at one center.Ann Intern Med1980; 92: 609–613.
13.
BagdadeI.D., PorteD.Jr., BiennanE.L.Hypertriglyceridemia: A metabolic consequence of chronic renal failure.New Engl I Med1968; 279: 181–185.
14.
BrunzellI.D., A1bersI.I., HaasLDPrevalence of serum lipid abnonnalities in chronic hemodialysis.Metabolism1977; 26: 903–910.
15.
IbelsL.D., ReardonM.F., NestelP.I.Plasma postheparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.I Lab Clin Med1976; 87: 648.
16.
CattranD.C., FentonS.S.A., WilsonD.R., SteinerO.Defective triglyceride removal in lipemia associated with peritoneal dialysis and hemodialysis.Ann Intern Med1976; 85: 29–33.
17.
IbelsL.S., SimonsL.A., KingIOStudies on the nature and causes of hyperlipemia, maintenance dialysis and renal transplantation.Q I Med1975; 44: 601.
18.
CasarettoA., MarchioroT., BagdadeI.Hyperlipidemia following renal transplantation.Trans Am Soc Artif Intern Organs1973; 19: 154.
19.
OreopoulosD.O., ClaytonS., DombrosNExperience with continuous ambulatory peritoneal dialysis (CAPD).Trans Am Soc Artif Intern Organs1979; 25: 95–97.
20.
LindholmB., KarlanderS.O., NorbeckHECarbohydrate and lipid metabolism in CAPD patients. In: AtkinsR.C., ThomsonN.M., FarrellP.C. eds. Peritoneal dialsyis.Churchill Livingstone, 1981: 198–210.
21.
RoncariD.A., BreckenridgeW.C., KhannaR., OreopoulosD.O.Rise in high density lipoprotein -cholesterol in some patients treated with CAPD.Perit Dial Bull1981; 1: 136–137.
ChanM.K., VargheseZ., PersaudI.W., BaillodR.A., MoorheadI.F.HDL cholesterol and intravenous fat tolerance in dialysis patients.Proc EDTA1980: 17: 247.
24.
Attm3nP.O.Lipid and carbohydrate metablism in uremia.E I Clin Invest1979; 9: 285–291.
25.
BischelM.D., BarbourB.Peritoneal dialysis with sorbitol versus dextrose dialysate.Nephron1974; 12: 449–463.
26.
RasibR.M., Moros10, KramerM.S., RosenbaumI.L.Hyperos molar coma complicating peritoneal dialysis with sorbitol dialysate.Ann Intern Med1970; 73: 993–994.
27.
Editorial.Recommendations on choice of peritoneal dialysis solution.Ann Intem Med1973: 78: 144–147.
28.
NolphK., HopkinsC., RubinJPolymer induced ultrafiltration in dialysis: High osmotic pressure due to impermeant polymer sodium.Trans Am Soc Artif Intern Organs1978; 24: 162–167.
29.
McGaryT.J., NolphK.D., KartinosN.J.Polyanions as osmotic agents in a simulated in vitro model of peritoneal dialysis.Trans Am Soc Artif Intern Organs1981; 27: 314–318.
30.
TwardowskiZ.J., NolphK.D., MooreH.L., McGaryT.Long dwell peritoneal dialysis exchanges in rats with poly acrylate and glucose asosmotic agent.Clin Res1982: 30: 80A.
31.
GjessingJ.The use of dextran as a dialysing fluid in peritoneal dialysis.Acta Med Scan1969; 185: 237–239.
32.
RubinJ., NolphK.D., McGaryT.Osmotic ultrafiltration with dextran sodium sulfate; potential for use in peritoneal dialysis.J Dialysis1979; 3: 251–264.
33.
WilliamsP., KayR., HarrisonJNutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium.Perit Dial Bull1981; 1: 82–87.
34.
WilliamsP., MarlissE.B., AndersonGHAmino acid absorption following intraperitoneal administration in CAPO patients.Perit Dial Bull1982; 2: 124–129.
35.
ThomasO.W., EdwardsJ.B., GilliganJEComplication following intravenous administration of solutions containing xylitol.Med J Aust1972; 1: 1238.
